L3W

General Information


DRACP ID  DRACP03889

Peptide Name   L3W

Sequence  LRRLRRRLRRLRRRLRRLRRRWRRRLRRLRRRLRRLRRRLRRL

Sequence Length  43

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C263H504N134O44

Absent amino acids  ACDEFGHIKMNPQSTVY

Common amino acids  R

Mass  699701

Pl  13.96

Basic residues  30

Acidic residues  0

Hydrophobic residues  13

Net charge  30

Boman Index  -38623

Hydrophobicity  -210

Aliphatic Index  108.84

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  130.95

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28230992

Title  Novel Design of Heptad Amphiphiles To Enhance Cell Selectivity, Salt Resistance, Antibiofilm Properties and Their Membrane-Disruptive Mechanism

Doi Not available

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  14004

DRACP is developed by Dr.Zheng's team.